together with our patients, we strive to extend survival in some of the most aggressive forms of cancer
about us
our therapy
our pipeline
careers
news and media
investor relations
NEWS
Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of TTFields Therapy for Pancreatic Cancer
PANOVA-3 met its primary endpoint with a statistically significant improvement in overall survival for patients with unresectable, locally advanced pancreatic adenocarcinoma treated in the first line with TTFields concomitant with gemcitabine and nab-paclitaxel.
patient forward
We are a global oncology company striving to extend survival in some of the most aggressive forms of cancer. Learn more about our company and our mission through stories about patients, our colleagues, our collaborators and our culture.
patient experience
Janice Armbrust
Decades of hiking and rock climbing taught Janice Armbrust how to handle the greatest uphill battle of her life: one day — one step — at a time.
patient experience
Mike Hugo
Mike Hugo has packed a lot fo life in his years, and he wants to teach his daughters to live with the same vigor and resolve.
patient experience
Jovan Knutson
A glioblastoma diagnosis led Jovan Knutson to reevaluate what is most important to her. She has found joy in the moment, and with it, a renewed sense of purpose and resilience.